Xeris Biopharma Holdings Statistics

Total Valuation

XERS has a market cap or net worth of $1.05 billion. The enterprise value is $1.20 billion.

Market Cap	1.05B
Enterprise Value	1.20B

Important Dates

The next confirmed earnings date is Thursday, May 7, 2026, before market open.

Earnings Date	May 7, 2026
Ex-Dividend Date	n/a

Share Statistics

XERS has 172.43 million shares outstanding. The number of shares has increased by 17.69% in one year.

Current Share Class	172.43M
Shares Outstanding	172.43M
Shares Change (YoY)	+17.69%
Shares Change (QoQ)	+1.38%
Owned by Insiders (%)	5.11%
Owned by Institutions (%)	59.21%
Float	163.61M

Valuation Ratios

The trailing PE ratio is 1,898.97 and the forward PE ratio is 51.83.

PE Ratio	1,898.97
Forward PE	51.83
PS Ratio	3.60
Forward PS	2.69
PB Ratio	74.07
P/TBV Ratio	n/a
P/FCF Ratio	37.66
P/OCF Ratio	36.74
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 32.36, with an EV/FCF ratio of 42.92.

EV / Earnings	2,164.06
EV / Sales	4.11
EV / EBITDA	32.36
EV / EBIT	48.16
EV / FCF	42.92

Financial Position

The company has a current ratio of 2.19, with a Debt / Equity ratio of 18.85.

Current Ratio	2.19
Quick Ratio	1.48
Debt / Equity	18.85
Debt / EBITDA	5.73
Debt / FCF	9.24
Interest Coverage	0.86

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	4.40%
Return on Invested Capital (ROIC)	6.06%
Return on Capital Employed (ROCE)	9.09%
Weighted Average Cost of Capital (WACC)	9.52%
Revenue Per Employee	$670,908
Profits Per Employee	$1,274
Employee Count	435
Asset Turnover	0.83
Inventory Turnover	0.73

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +41.30% in the last 52 weeks. The beta is 0.99, so XERS's price volatility has been similar to the market average.

Beta (5Y)	0.99
52-Week Price Change	+41.30%
50-Day Moving Average	5.98
200-Day Moving Average	7.04
Relative Strength Index (RSI)	52.67
Average Volume (20 Days)	1,406,857

Short Selling Information

The latest short interest is 15.74 million, so 9.13% of the outstanding shares have been sold short.

Short Interest	15.74M
Short Previous Month	16.41M
Short % of Shares Out	9.13%
Short % of Float	9.62%
Short Ratio (days to cover)	9.41

Income Statement

In the last 12 months, XERS had revenue of $291.85 million and earned $554,000 in profits. Earnings per share was $0.00.

Revenue	291.85M
Gross Profit	249.28M
Operating Income	24.90M
Pretax Income	554,000
Net Income	554,000
EBITDA	37.05M
EBIT	24.90M
Earnings Per Share (EPS)	$0.00

Full Income Statement

Balance Sheet

The company has $111.04 million in cash and $258.10 million in debt, giving a net cash position of -$147.06 million or -$0.85 per share.

Cash & Cash Equivalents	111.04M
Total Debt	258.10M
Net Cash	-147.06M
Net Cash Per Share	-$0.85
Equity (Book Value)	13.69M
Book Value Per Share	0.08
Working Capital	130.74M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was $28.63 million and capital expenditures -$696,000, giving a free cash flow of $27.93 million.

Operating Cash Flow	28.63M
Capital Expenditures	-696,000
Depreciation & Amortization	12.16M
Net Borrowing	n/a
Free Cash Flow	27.93M
FCF Per Share	$0.16

Full Cash Flow Statement

Margins

Gross margin is 85.41%, with operating and profit margins of 8.53% and 0.19%.

Gross Margin	85.41%
Operating Margin	8.53%
Pretax Margin	0.19%
Profit Margin	0.19%
EBITDA Margin	12.70%
EBIT Margin	8.53%
FCF Margin	9.57%

Dividends & Yields

XERS does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-17.69%
Shareholder Yield	-17.69%
Earnings Yield	0.05%
FCF Yield	2.66%

Analyst Forecast

The average price target for XERS is $10.83, which is 77.83% higher than the current price. The consensus rating is "Buy".

Price Target	$10.83
Price Target Difference	77.83%
Analyst Consensus	Buy
Analyst Count	6
Revenue Growth Forecast (5Y)	10.36%
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

XERS has an Altman Z-Score of 0.44 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.44
Piotroski F-Score	7